Skip to Content
myAACR
Donate Today

Innovators in Discovery

Home > Patients, Caregivers, and Advocates > Innovators in Cancer

Cancer researchers, physician-scientists, and others are driving progress against cancer with discoveries that are advancing prevention and transforming care.

Why Don’t Our Bodies Fight Cancer for Us?

Why Don’t Our Bodies Fight Cancer for Us?

James P. Allison, PhD: Untangling the complexities of the immune system to pioneer cancer immunotherapy.

Read more
Charles L. Sawyers, MD, Fellow of the AACR Academy

Charles L. Sawyers, MD, Fellow of the AACR Academy

As a physician scientist and leader in the development of targeted therapies for cancer, Dr. Sawyers investigates the signaling pathways that drive the growth and drug resistance of cancer cells.

Learn More
Judy E. Garber, MD, MPH, Fellow of the AACR Academy

Judy E. Garber, MD, MPH, Fellow of the AACR Academy

An internationally recognized leader in clinical and translational research on breast cancer, Dr. Garber developed one of the first cancer risk and prevention clinics where programs are now being expanded to several types of cancer.

Learn More
Closing Disparities Through Genetic Testing

Closing Disparities Through Genetic Testing

Dr. Olufunmilayo Olopade, a physician-scientist and director of the Center for Clinical Cancer Genetics at the University of Chicago Medical Center seeks widespread use of testing to encourage prevention and early detection of deadly cancers.

Read more in Leading Discoveries magazine
Ronald M. Evans, PhD, Fellows of the AACR Academy

Ronald M. Evans, PhD, Fellows of the AACR Academy

A renowned authority on hormones and their role in disease, Dr. Evans has conducted research that has led to the discovery of nearly 50 nuclear hormone receptors.

Learn More
Susan B. Horwitz, PHD, Fellow of the AACR Academy

Susan B. Horwitz, PHD, Fellow of the AACR Academy

Dr. Horwitz's contributions to the field encompass agents that have served as prototypes for some of the most important drugs currently in clinical use. Her most seminal contribution has been in the development of Taxol®, a drug isolated from the yew plant, Taxus brevifolia.

Learn More
Tackling Cancer’s Toughest Problems

Tackling Cancer’s Toughest Problems

For Michael A. Caligiuri, MD, the 2017-2018 AACR President, it is unacceptable that advances in cancer care and treatment don’t benefit everyone equally. Dr. Caligiuri made cancer health disparities one of the signature issues of his tenure as AACR President. 

Read more in Leading Discoveries magazine
Pioneering Personalized Medicine

Pioneering Personalized Medicine

Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.

Read more
A Visionary With a Focus on Patients

A Visionary With a Focus on Patients

Physician-scientist and Fellow of the AACR Academy William N. Hait, MD, PhD, encourages collaborations to intercept, prevent, and treat cancer. Throughout a varied career in academia and industry, Dr. Hait has kept his sights on benefiting patients.

Read more in Leading Discoveries magazine
Show More